# SOLTI Breast Cancer Molecular Screening Program (AGATA)

> **NCT02445482** · — · COMPLETED · sponsor: **SOLTI Breast Cancer Research Group** · enrollment: 260 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT02445482
- **Lead sponsor:** SOLTI Breast Cancer Research Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2017-06
- **Final completion:** 2018-12
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02445482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02445482, "SOLTI Breast Cancer Molecular Screening Program (AGATA)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02445482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*